Nasdaq:US$ () | HKEX:HK$28.20 (-1.15) | AIM:£2.74 (+0)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF